Gufic BioSciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 227.81 | 205.40 | 209.66 |
| Operating Expense | 194.58 | 178.38 | 173.85 |
| Net Profit | 12.07 | 7.97 | 19.32 |
| Net Profit Margin | 5.30 | 3.88 | 9.21 |
| Earning Per Share | 1.20 | 0.80 | 1.93 |
| EBIDTA | 31.24 | 24.50 | 32.80 |
| Effective Tax Rate | 6.68 | 1.07 | 11.03 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 227.81 |
| Operating Expense | 194.58 |
| Net Profit | 12.07 |
| Net Profit Margin | 5.30 |
| Earning Per Share | 1.20 |
| EBIDTA | 31.24 |
| Effective Tax Rate | 6.68 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 819.81 | 806.67 | 690.62 |
| Operating Expenses Annual | 683.41 | 659.37 | 555.97 |
| Operating Profit Annual | 140.01 | 149.48 | 137.23 |
| Interest Annual | 24.52 | 16.79 | 8.22 |
| Depreciation | 14.18 | 9.89 | 15.52 |
| Net Profit Annual | 69.93 | 86.14 | 79.70 |
| Tax Annual | 24.49 | 29.54 | 27.02 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 819.81 |
| Operating Expenses Annual | 683.41 |
| Operating Profit Annual | 140.01 |
| Interest Annual | 24.52 |
| Depreciation | 14.18 |
| Net Profit Annual | 69.93 |
| Tax Annual | 24.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.13 | 28.60 | 11.61 |
| Cash Flow from Operations | 122.78 | -7.46 | -26.59 |
| Cash Flow from Investing | -71.79 | -102.40 | -190.73 |
| Cash Flow from Financing | -37.20 | 82.38 | 234.31 |
| Cash Flow at the End | 14.91 | 1.13 | 28.60 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1.13 |
| Cash Flow from Operations | 122.78 |
| Cash Flow from Investing | -71.79 |
| Cash Flow from Financing | -37.20 |
| Cash Flow at the End | 14.91 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 17.08 | 18.53 | 19.87 |
| PBIT Margin (%) | 14.51 | 16.42 | 16.64 |
| PBT Margin (%) | 13.92 | 15.44 | 14.62 |
| Net PROFIT Margin (%) | 8.53 | 10.68 | 11.54 |
| Return On Networth / Equity (%) | 12.33 | 19.57 | 25.84 |
| Return On Networth /Employed (%) | 12.88 | 16.70 | 21.87 |
| Return On Assets (%) | 7.59 | 10.89 | 15.12 |
| Total Debt / Equity (X) | 0.59 | 0.76 | 0.65 |
| Asset Turnover Ratio (%) | 0.89 | 1.02 | 1.31 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 17.08 |
| PBIT Margin (%) | 14.51 |
| PBT Margin (%) | 13.92 |
| Net PROFIT Margin (%) | 8.53 |
| Return On Networth / Equity (%) | 12.33 |
| Return On Networth /Employed (%) | 12.88 |
| Return On Assets (%) | 7.59 |
| Total Debt / Equity (X) | 0.59 |
| Asset Turnover Ratio (%) | 0.89 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 505.99 | 158.89 | 159.57 |
| Total Current Assets Annual | 623.78 | 600.47 | 464.11 |
| Non Current Assets Annual | 545.85 | 492.07 | 397.05 |
| Total Shareholders Funds Annual | 601.36 | 532.56 | 347.81 |
| Total Assets Annual | 1,169.63 | 1,092.54 | 861.16 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 505.99 |
| Total Current Assets Annual | 623.78 |
| Non Current Assets Annual | 545.85 |
| Total Shareholders Funds Annual | 601.36 |
| Total Assets Annual | 1,169.63 |
EPS (INR)
Expected
1.30
Reported
1.30
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by Infinity%
